Search results for " Pall" in Articles / App Notes
Article
Cytiva and Pall Corporation Investing 1.5 Billion USD Over Two Years to Meet Growing Demand for Biotechnology Solutions
Click here to read more >>
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services acros…
Article
The New World of Biopharmaceutical Manufacturing
…ce, Global Technical Operations at Merck; Helene Pora, PhD, vice-president, Single-Use Technologies, Pall Life Sciences; Peter Levison, senior marketing director, Downstream Processing, Pall Life Sci…
Article
Process Chromatography Selection for Downstream Processing Applications
…MSAT at MilliporeSigma; and Peter Levison, PhD, senior marketing director of Downstream Processes at Pall Life Sciences discuss important considerations in process chromatography selection.
Sep…
Article
Single-use Bioreactors Have Reached the Big Time
…n perspective, according to Annelies Onraedt, director of marketing for cell culture technologies at Pall Life Sciences. “When considering the workflow and objectives of running bioreactors, recent d…
Article
Challenges and Trends in Biopharma Facility Design
BioPharm International spoke with Daniella Kranjac, head, evaluation and offering, Enterprise Solutions, at Cytiva; Mario Philips, president of Single-Use Technologies at Pall Life Sciences; Par Almhe…
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
Overall process scalability and robustness, says Todd Sanderson, senior R&D manager for Pall Biotech, are dependent on the performance of the bioreactor whether it is adherent- or suspension-based. “T…
Article
Supply Chain Challenges for Single-Use Systems
…s at Entegris; and Helene Pora, vice-president of Technical Communication and Regulatory Strategy at Pall about some of the issues facing the industry as companies look to SUS for biopharmaceutical m…
Article
Improving Process-Scale Chromatography
…chromatography, according to Peter Levison, senior marketing director for downstream processing with Pall Life Sciences. These resins contain simple multimodal ligands with functional groups that int…
Article
Achieving Process Balance with Perfusion Bioreactors
…est in perfusion cell culture,” notes Peter Levison, executive director of business development at Pall Biotech.
The differences in processing conditions for batch and perfusion cell culture lead…
Article
Maximum Output Starts with Optimized Upstream Processing
By Cynthia A. Challener
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
Significant growth in the develo…